Streptococcus pneumoniae causes invasive pneumococcal disease (IPD), leading to high morbidity and mortality worldwide. Although nonvaccine serotypes constitute a major issue in the aspect of invasive pneumococcal disease, serotypes included in PCV13 still continue to be a problem. Vaccination with very high coverage and multicenter surveillance studies would be beneficial to decrease carriage of vaccine and nonvaccine serotypes of pneumococcus and monitor changing seroepidemiology
The aim was to analyse invasive pneumococcal disease (IPD) serotypes in children aged ⩽17 years acco...
Vaccination with the 13-valent conjugated pneumococcal disease (PCV13) has reduced invasive pneumoco...
Introduction: Pediatric pneumococcal pneumonia complicated by parapneumonic pleural effusion/empyema...
Streptococcus pneumoniae is the most common cause of complicated pneumonia. Pneumococcal necrotizing...
BACKGROUND:Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13) has reduced invasi...
Streptococcus pneumoniae is both a common inhabitant of the human nasopharynx and a leading cause of...
<p><em>Streptococcus pneumoniae</em> (SP) is a gram-positive bacterium with more than 90 known serot...
Despite use of 7-valent pneumococcal conjugate vaccine, incidence of pleural effusion and empyema (p...
AbstractBackgroundChanges in serotype distribution have been induced after pneumococcal conjugate va...
Defining the propensity of Streptococcus pneumoniae (SP) serotypes to invade sterile body sites foll...
Background/PurposeEmerging non-7-valent pneumococcal conjugate vaccine (PCV7) serotypes have replace...
Objectives Burden of pneumococcal disease depends on the prevalence and invasive disease potential o...
Streptococcus pneumoniae continues to cause significant disease burden. Whilst pneumococcal conjugat...
Emerging non-7-valent pneumococcal conjugate vaccine (PCV7) serotypes have replaced PCV7 serotypes i...
Streptococcus pneumoniae causes invasive and noninvasive infections. Among infectious diseases, inva...
The aim was to analyse invasive pneumococcal disease (IPD) serotypes in children aged ⩽17 years acco...
Vaccination with the 13-valent conjugated pneumococcal disease (PCV13) has reduced invasive pneumoco...
Introduction: Pediatric pneumococcal pneumonia complicated by parapneumonic pleural effusion/empyema...
Streptococcus pneumoniae is the most common cause of complicated pneumonia. Pneumococcal necrotizing...
BACKGROUND:Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13) has reduced invasi...
Streptococcus pneumoniae is both a common inhabitant of the human nasopharynx and a leading cause of...
<p><em>Streptococcus pneumoniae</em> (SP) is a gram-positive bacterium with more than 90 known serot...
Despite use of 7-valent pneumococcal conjugate vaccine, incidence of pleural effusion and empyema (p...
AbstractBackgroundChanges in serotype distribution have been induced after pneumococcal conjugate va...
Defining the propensity of Streptococcus pneumoniae (SP) serotypes to invade sterile body sites foll...
Background/PurposeEmerging non-7-valent pneumococcal conjugate vaccine (PCV7) serotypes have replace...
Objectives Burden of pneumococcal disease depends on the prevalence and invasive disease potential o...
Streptococcus pneumoniae continues to cause significant disease burden. Whilst pneumococcal conjugat...
Emerging non-7-valent pneumococcal conjugate vaccine (PCV7) serotypes have replaced PCV7 serotypes i...
Streptococcus pneumoniae causes invasive and noninvasive infections. Among infectious diseases, inva...
The aim was to analyse invasive pneumococcal disease (IPD) serotypes in children aged ⩽17 years acco...
Vaccination with the 13-valent conjugated pneumococcal disease (PCV13) has reduced invasive pneumoco...
Introduction: Pediatric pneumococcal pneumonia complicated by parapneumonic pleural effusion/empyema...